Table 1.
Comparison of the baseline clinical, demographic, laboratory, electrocardiographic, and echocardiographic parameters
| RVOT n = 61 | LVOT n = 62 | p | |
|---|---|---|---|
| Age (years) | 43.1 ± 13.0 | 49.2 ± 14.2 | .015 |
| Gender (Male,%) | 24 (39.3) | 29 (46 .8) | .405 |
| Hemoglobin (g/dl) | 13.4 ± 2.0 | 13.3 ± 1.6 | .903 |
| Creatinine (mg/dl) | 0.70 ± 0.21 | 0.76 ± 0.28 | .256 |
| LV ejection fraction (%) | 60.7 ± 7.1 | 58.7 ± 6.3 | .128 |
| QRS duration (ms) | 139.4 ± 15.7 | 135.3 ± 20.1 | .203 |
| V1‐2 SRd (mV) | 2.46 ± 0.74 | 0.52 ± 1.13 | <.001 |
| Prior ablation history (n,%) | 5 (8.2) | 2 (3.2) | .273 |
| TICMP, n (%) | 4 (6.6) | 4 (6.5) | .981 |
| Patients treated with CARTO (n,%) | 7 (11.5) | 15 (24.2) | .066 |
Bold values indicate statistical significance. V1‐2 SRd, S‐R difference in V1‐V2, LVOT, left ventricular outflow tract; RVOT, right ventricular outflow tract; TICMP, tachycardia‐induced cardiomyopathy.